Audit 350392

FY End
2024-06-30
Total Expended
$9.34M
Findings
0
Programs
2
Organization: Stc Healthcare Partners, LLC (PA)
Year: 2024 Accepted: 2025-03-30
Auditor: Kpmg

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

Contacts

Name Title Type
ESHBUN7C4AB5 Terry Raymond Auditee
2154276507 Nicholas Paranto Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule, except for the program expenditures described in the following paragraph, are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, or 45 CFR Part 75 Appendix IX, Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Expenditures reported on the Schedule are recognized as follows: • COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution, federal assistance listing number 93.498, represents the total expenditures and/or lost revenues from the Period 6 report submissions to the PRF Reporting Portal. Period 6 is based on payments received from July 1, 2022 through December 31, 2022, with a period of availability of expenses from January 1, 2020 through December 31, 2023 and/or lost revenues from January 1, 2020 through June 30, 2023. De Minimis Rate Used: N Rate Explanation: N/A The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal award activities of STC Healthcare Partners, LLC and its subsidiaries (the Company) under programs of the federal government for the year ended June 30, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected portion of the operations of the Company, and it is not intended to and does not present the consolidated financial position, changes in net assets, or cash flows of the Company. There were no federal funds passed through to subrecipients for the year ended June 30, 2024.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule, except for the program expenditures described in the following paragraph, are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, or 45 CFR Part 75 Appendix IX, Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Expenditures reported on the Schedule are recognized as follows: • COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution, federal assistance listing number 93.498, represents the total expenditures and/or lost revenues from the Period 6 report submissions to the PRF Reporting Portal. Period 6 is based on payments received from July 1, 2022 through December 31, 2022, with a period of availability of expenses from January 1, 2020 through December 31, 2023 and/or lost revenues from January 1, 2020 through June 30, 2023. De Minimis Rate Used: N Rate Explanation: N/A Expenditures reported on the Schedule, except for the program expenditures described in the following paragraph, are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, or 45 CFR Part 75 Appendix IX, Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Expenditures reported on the Schedule are recognized as follows: COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution, federal assistance listing number 93.498, represents the total expenditures and/or lost revenues from the Period 6 report submissions to the PRF Reporting Portal. Period 6 is based on payments received from July 1, 2022 through December 31, 2022, with a period of availability of expenses from January 1, 2020 through December 31, 2023 and/or lost revenues from January 1, 2020 through June 30, 2023.
Title: Indirect Costs Accounting Policies: Expenditures reported on the Schedule, except for the program expenditures described in the following paragraph, are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, or 45 CFR Part 75 Appendix IX, Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Expenditures reported on the Schedule are recognized as follows: • COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution, federal assistance listing number 93.498, represents the total expenditures and/or lost revenues from the Period 6 report submissions to the PRF Reporting Portal. Period 6 is based on payments received from July 1, 2022 through December 31, 2022, with a period of availability of expenses from January 1, 2020 through December 31, 2023 and/or lost revenues from January 1, 2020 through June 30, 2023. De Minimis Rate Used: N Rate Explanation: N/A The Company has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: Provider Relief Fund Accounting Policies: Expenditures reported on the Schedule, except for the program expenditures described in the following paragraph, are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, or 45 CFR Part 75 Appendix IX, Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Expenditures reported on the Schedule are recognized as follows: • COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution, federal assistance listing number 93.498, represents the total expenditures and/or lost revenues from the Period 6 report submissions to the PRF Reporting Portal. Period 6 is based on payments received from July 1, 2022 through December 31, 2022, with a period of availability of expenses from January 1, 2020 through December 31, 2023 and/or lost revenues from January 1, 2020 through June 30, 2023. De Minimis Rate Used: N Rate Explanation: N/A The Provider Relief Fund expenditures reported on the Schedule include the following providers and amounts reported for period 6 in the PRF Reporting Portal: STC Healthcare Partners, LLC - 84-3467958 - $7,694,765